Table 4 Demographic Information, SCr Levels, and eGFR prior and Subsequent to fluorescein angiography
From: Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography
Patient No. | Age | Sex | Pre-SCr (mg/dL) | Post-SCr (mg/dL) | Change in SCr (mg/dL) | Pre-eGFR (mL/min/1.73 m2) | Post-eGFR (mL/min/1.73 m2) |
|---|---|---|---|---|---|---|---|
1 | 53 | M | 0.84 | 2.08 | 1.24 | 90.0 | 34.0 |
2 | 62 | M | 1.50 | 2.30 | 0.80 | 50.5 | 30.8 |